Nektar Therapeutics | D: Filing D
Mar 19 16:42 ET
Nektar Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-TCG Crossover GP II, LLC(9.9%),TCG Crossover Fund II, L.P.(9.9%), etc.
Mar 15 16:27 ET
Nektar Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner Deep Track Capital, LP
Mar 14 16:37 ET
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Zalevsky Jonathan
Feb 22 20:23 ET
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Wilson Mark Andrew
Feb 22 20:23 ET
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer ROBIN HOWARD W
Feb 22 20:18 ET
Nektar Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(0%),Peter Kolchinsky(0%), etc.
Feb 14 17:10 ET
Nektar Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Citadel Advisors LLC(3.0%),Citadel Advisors Holdings LP(3.0%), etc.
Feb 14 17:05 ET
Nektar Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(9.65%),Deep Track Biotechnology Master Fund, Ltd.(9.65%), etc.
Feb 14 08:58 ET
Nektar Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(6.31%)
Feb 13 22:42 ET
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Zalevsky Jonathan
Dec 15, 2023 18:07 ET
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Legal Officer Wilson Mark Andrew
Dec 15, 2023 18:05 ET
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer ROBIN HOWARD W
Dec 15, 2023 18:05 ET
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Zalevsky Jonathan
Nov 20, 2023 21:02 ET
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Legal Officer Wilson Mark Andrew
Nov 20, 2023 21:00 ET
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer ROBIN HOWARD W
Nov 20, 2023 20:58 ET
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GREER R SCOTT
Sep 21, 2023 20:07 ET
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director WHITFIELD ROY A
Sep 20, 2023 20:11 ET
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Curet Myriam
Sep 20, 2023 20:09 ET
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director CHESS ROBERT
Sep 20, 2023 20:08 ET
No Data
No Data